Neogenomics (NEO) Return on Invested Capital (2013 - 2020)

Neogenomics (NEO) has 8 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2020.

• Quarterly Return on Invested Capital fell 1.0% year-over-year to 0.0% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 0.0% (down 1.0% YoY) and the FY2019 annual result came in at 0.03%, up 2.0% from the prior year.
• Return on Invested Capital improved to 0.0% in Q4 2020, from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2019 to a low of 0.0% in Q3 2020.
• A 5-year average of 0.0% and a median of 0.0% in 2019 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2018 — Return on Invested Capital gained 1 bps — and 2019, when it slipped 1 bps.
• Tracing NEO's Return on Invested Capital over 5 years: stood at 0.0% in 2016, then plunged by 91 bps to 0.0% in 2017, then surged by 681 bps to 0.0% in 2018, then jumped by 579 bps to 0.01% in 2019, then slumped by 54 bps to 0.0% in 2020.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2020), 0.0% (Q3 2020), and 0.0% (Q2 2020), per Business Quant data.